Literature DB >> 34780087

South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature.

Hossein Mirhendi1,2, Arezou Charsizadeh3, Shima Aboutalebian1, Masoud Mohammadpour4, Bahram Nikmanesh5, Theun de Groot6,7, Jacques F Meis6,7,8, Hamid Badali9,10.   

Abstract

Candida meningitis is a rare life-threatening yeast infection mostly involving immunocompromised or paediatric patients undergoing neurosurgical procedures or shunt placement. Due to difficulties in diagnosis because of diverse clinical manifestations, the number of patients affected is most likely underestimated. Therefore, the correct diagnosis may be delayed for months, and accurate species identification is highly recommended for administering appropriate antifungal therapy. We report the first case of fluconazole-resistant Candida auris meningitis in a paediatric patient in Iran. This strain was probably imported, as it genotypically belonged to Clade I from South Asia. Furthermore, we include a literature review of C auris meningitis cases, as the number of cases with C auris meningitis has increased with reports from the United Kingdom, India and Iran. This problem might increase further in the era of COVID-19 due to attrition of experienced healthcare personnel and a high workload of hospital healthcare workers. To understand the precise prevalence of this emerging multidrug resistance pathogen, epidemiological surveillance studies are urgently warranted.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  zzm321990Candidazzm321990; antifungal susceptibility; candidaemia; meningitis; typing

Mesh:

Substances:

Year:  2021        PMID: 34780087     DOI: 10.1111/myc.13396

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Confirmation of fifth Candida auris clade by whole genome sequencing.

Authors:  Bram Spruijtenburg; Hamid Badali; Mahdi Abastabar; Hossein Mirhendi; Sadegh Khodavaisy; Joobin Sharifisooraki; Mojtaba Taghizadeh Armaki; Theun de Groot; Jacques F Meis
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

2.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

3.  In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.

Authors:  Lajos Forgács; Andrew M Borman; Renátó Kovács; Dávid Balázsi; Zoltán Tóth; Bence Balázs; Chiu Chun-Ju; Gábor Kardos; Ilona Kovacs; László Majoros
Journal:  J Fungi (Basel)       Date:  2022-05-11

4.  Multiplex size marker (YEAST PLEX) for rapid and accurate identification of pathogenic yeasts.

Authors:  Shima Aboutalebian; Shahram Mahmoudi; Arezoo Charsizadeh; Bahram Nikmanesh; Mahnaz Hosseini; Hossein Mirhendi
Journal:  J Clin Lab Anal       Date:  2022-03-22       Impact factor: 3.124

Review 5.  Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysis.

Authors:  Narges Vaseghi; Joobin Sharifisooraki; Hossein Khodadadi; Sanam Nami; Fatemeh Safari; Fatemeh Ahangarkani; Jacques F Meis; Hamid Badali; Hamid Morovati
Journal:  Mycoses       Date:  2022-05-25       Impact factor: 4.931

6.  Emergence of Candida auris in intensive care units in Algeria.

Authors:  Hanane Zerrouki; Ahmad Ibrahim; Sid-Ahmed Rebiahi; Yamina Elhabiri; Djamel-Eddine Benhaddouche; Theun de Groot; Jacques F Meis; Jean-Marc Rolain; Fadi Bittar
Journal:  Mycoses       Date:  2022-05-31       Impact factor: 4.931

Review 7.  The Menace of Candida auris Epidemic Amidst the COVID-19 Pandemic: A Systematic Review.

Authors:  Hala Najeeb; Sarush Ahmed Siddiqui; Zahra Anas; Syed Hasan Ali; Shajie Ur Rehman Usmani; Fareeha Jawed; Hafsa Nazir Jatoi
Journal:  Diseases       Date:  2022-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.